SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-20-000468
Filing Date
2020-01-10
Accepted
2020-01-10 17:27:53
Documents
18
Period of Report
2020-01-10
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8k.htm 8-K 49959
2 ex99-1.htm EX-99.1 22144
3 ex99-2.htm EX-99.2 14773
4 image_002.jpg GRAPHIC 6348
5 ex99-2_001.jpg GRAPHIC 41859
6 ex99-2_002.jpg GRAPHIC 54726
7 ex99-2_003.jpg GRAPHIC 99742
8 ex99-2_004.jpg GRAPHIC 94860
9 ex99-2_005.jpg GRAPHIC 77874
10 ex99-2_006.jpg GRAPHIC 96720
11 ex99-2_007.jpg GRAPHIC 122152
12 ex99-2_008.jpg GRAPHIC 83446
13 ex99-2_009.jpg GRAPHIC 88317
14 ex99-2_010.jpg GRAPHIC 116386
15 ex99-2_011.jpg GRAPHIC 89222
16 ex99-2_012.jpg GRAPHIC 96407
17 ex99-2_013.jpg GRAPHIC 86496
18 ex99-2_014.jpg GRAPHIC 21978
  Complete submission text file 0001493152-20-000468.txt   1709977
Mailing Address 1010 ATLANTIC AVENUE SUITE 102 ALAMEDA CA 94501
Business Address 1010 ATLANTIC AVENUE SUITE 102 ALAMEDA CA 94501 510-775-0515
OncoCyte Corp (Filer) CIK: 0001642380 (see all company filings)

IRS No.: 271041563 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37648 | Film No.: 20522044
SIC: 2835 In Vitro & In Vivo Diagnostic Substances